A phase II trial of regorafenib for advanced urothelial cancer (aUC) following prior chemotherapy

被引：1
|
作者：
Naik, Gurudatta
Vaishampayan, Ulka N.
Nabell, Lisle
De Shazo, Mollie R.
Nandagopal, Lakshminarayanan
Grivas, Petros
Morgan, Charity
Hardwick, Pamela
Sonpavde, Guru
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Wayne State Univ, Detroit, MI USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
498
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer
    Alexandre Silva de Azevedo, Carla Rameri
    Santos Thuler, Luiz Claudio
    Gonsalves de Mello, Maria Julia
    de Oliveira Lima, Jurema Telles
    Fassizoli da Fonte, Ana Luiza
    Santos Fontao, Diogenes Fernando
    Gomes Carneiro, Vandre Cabral
    Cabral Chang, Tien Man
    Ferreira, Carlos Gil
    GYNECOLOGIC ONCOLOGY, 2017, 146 (03) : 560 - 565
  • [32] Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer
    Akira Tsuburaya
    Naoki Nagata
    Haruhiko Cho
    Naoki Hirabayashi
    Michiya Kobayashi
    Hiroshi Kojima
    Yasuhiro Munakata
    Ryoji Fukushima
    Yoichi Kameda
    Tadakazu Shimoda
    Koji Oba
    Junichi Sakamoto
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1309 - 1314
  • [33] Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer
    Tsuburaya, Akira
    Nagata, Naoki
    Cho, Haruhiko
    Hirabayashi, Naoki
    Kobayashi, Michiya
    Kojima, Hiroshi
    Munakata, Yasuhiro
    Fukushima, Ryoji
    Kameda, Yoichi
    Shimoda, Tadakazu
    Oba, Koji
    Sakamoto, Junichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1309 - 1314
  • [34] Phase I study of gemcitabine (GEM) & paclitaxel (TX) in patients (P) with advanced urothelial cancer (AUC).
    Garcia-Arroyo, FR
    Constenia, M
    Lorenzo, I
    Carrete, N
    Rey, C
    Campos, B
    Palacios, P
    ANNALS OF ONCOLOGY, 2000, 11 : 79 - 79
  • [35] Response and outcomes to immune checkpoint inhibitors (ICI) in advanced urothelial cancer (aUC) based on prior intravesical BCG.
    Talukder, Rafee
    Makrakis, Dimitrios
    Castellano, Daniel
    Koshkin, Vadim S.
    Alva, Ajjai Shivaram
    Stewart, Tyler F.
    Santos, Victor Sacristan
    Jain, Jayanshu
    Morales-Barrera, Rafael
    Grant, Michael
    Nelson, Ariel Ann
    Shreck, Evan
    Sankin, Alexander
    Zakopoulou, Roubini
    Rodriguez-Vida, Alejo
    Liu, Sandy
    Frobe, Ana
    Di Lorenzo, Giuseppe
    Grivas, Petros
    Khaki, Ali Raza
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Phase II study of eribulin (Halichondrin B analogue, E7389) in patients with advanced urothelial cancer (AUC) - California Cancer Consortium led NCI/CTEP-sponsored trial
    Quinn, D. I.
    Aparicio, A. M.
    Tsao-Wei, D. D.
    Groshen, S.
    Synold, T.
    Stadler, W. M.
    Massopust, K.
    Gandara, D.
    Lara, P. N.
    Newman, E.
    EJC SUPPLEMENTS, 2009, 7 (02): : 442 - 442
  • [37] Chemotherapy combined with regorafenib and immune checkpoint inhibitors as a first-line treatment for patients with advanced biliary tract cancer: a single arm phase II trial
    Liu, Jianwei
    Bai, Shilei
    Sun, Yanfu
    Hu, Lei
    Ge, Ruiliang
    Xue, Feng
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] CARBOPLATIN, METHOTREXATE AND VINBLASTIN (CARBO-MV) FOR ADVANCED UROTHELIAL CANCER - A PHASE-II TRIAL
    KLOCKER, J
    PONT, J
    SCHUMER, J
    PRUGER, J
    KIENZER, H
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (04): : 328 - 330
  • [39] Regorafenib, Ipilimumab, and Nivolumab for Patients With Microsatellite Stable Colorectal Cancer and Disease Progression With Prior Chemotherapy A Phase 1 Nonrandomized Clinical Trial
    Fakih, Marwan
    Sandhu, Jaideep
    Lim, Dean
    Li, Xiaochen
    Li, Sierra
    Wang, Chongkai
    JAMA ONCOLOGY, 2023, 9 (05) : 627 - 634
  • [40] Hyperthermic intraperitoneal chemotherapy following gastrectomy for the prevention of carcinomatosis in advanced gastric cancer: Nonrandomized phase II prospective trial.
    Murata, Satoshi
    Naito, Hiroyuki
    Yamamoto, Hiroshi
    Yamaguchi, Tsuyoshi
    Miyake, Tohru
    Mekata, Eiji
    Shimizu, Tomoharu
    Shiomi, Hisanori
    Naka, Shigeyuki
    Sonoda, Hiromichi
    Mori, Tsuyoshi
    Akabori, Hiroya
    Kawai, Yuki
    Cho, Hirotomi
    Kubota, Yoshihiro
    Umeda, Tomoko
    Endo, Yoshihiro
    Abe, Hajime
    Kurumi, Yoshimasa
    Tani, Tohru
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345